Check your drug: what each 2027 FEHB and PSHB plan charges by tier
Update, November 15, 2026: each kind of drug now goes to the tier OPM names for it on each plan, and Tier 5 and Tier 6 are read. Corrected to match OPM's latest plan files (OPM's Public Use Files).
Federal Benefits Open Season for plan year 2027 runs November 9 to December 14, 2026.
* Nine FEHB plans end after 2026. If you are in one and do not pick a new plan by December 14, OPM enrolls you in Compass Rose Standard. See the nineLoading the plans…
Pick up to four. Each one shows its drug list, its brochure, and what one fill costs on every tier.
The name finds every passage where a brochure names it; the price turns each tier into dollars. Both stay on this device; nothing is saved or sent.
Every plan at one tierEvery 2027 plan option, side by side at one tier you pick
A drug can sit on a different tier in each plan. Change the tier on any plan to match that plan’s list.
Spot a number that looks wrong? Tell us. Everything here runs on your device, and nothing you enter leaves it.
How the figures are built
From OPM’s 2027 plan files: each plan’s summary for Tier 1 to Tier 6, with the name OPM gives each tier. Plans number their tiers differently (on some, Tier 2 is a second generic tier and preferred brand is Tier 3), so each kind of drug here goes to the tier OPM names for it on that plan, and the card shows which tier that is. Where we read the plan’s brochure for a per-fill limit (a percent up to a dollar cap), the brochure’s figure is shown with its page. Where a brochure states no limit, the page says so. In a high-deductible plan the deductible comes first.
Searched in each 2027 brochure’s changes for 2027, its prescription drug benefits, and its exclusions, quoted word for word with the page. Brochures name kinds of drugs (insulin, inhalers, biologics, contraceptives) far more often than brand names, so a brand you take may not appear. That says nothing about coverage: the drug list decides.
A plan’s Medicare drug plan has its own prices and list. This page reads the plan’s regular drug benefit only. That drug plan is Medicare Part D, so, in the brochures’ own words, the Income-Related Monthly Adjustment Amount (IRMAA) “is an amount you may pay in addition to your FEHB premium to enroll in and maintain Medicare prescription drug coverage” (RI 71-005, page 2; PSHB brochures say the same of the PSHB premium), and copay cards are limited there: “The PDP EGWP restricts the use of manufacturer copay assistance when the PDP EGWP is the primary payer” (Compass Rose, RI 71-028). The GLP-1 pages show each brochure’s Medicare drug plan passages for weight-loss drugs.
Before you decide
The plan decides coverage and claims under its brochure, and your employing office handles eligibility and enrollment. If a plan denies a claim, the brochure’s disputed claims section shows how to ask the plan to reconsider and then ask OPM to review it. Every brochure says it: “This brochure is the official statement of benefits.”
A drug’s tier, prior approval, step therapy, and quantity limits are set by each plan’s drug list, which can change during the year. The per-fill figures here are estimates from the plan’s own summary; your pharmacy and the plan’s drug price lookup give the real price. StandWatch is independent, does not act for OPM or any agency, and is not paid by any plan or drug maker. Full disclosures
Sources
OPM, FEHB plan information and brochures. OPM, PSHB. OPM, plan data files (Public Use Files).